
Join to view full profile
55 Fruit StYawkey 7BBoston, MA 02114
Phone+1 617-724-4000
Fax+1 617-643-8744
Dr. Choy is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Edwin Choy is an oncologist based in Boston, MA, with a subspecialty in sarcoma, chordoma, GIST, GCTB, TGCT, PVNS, and other connective tissue cancers. He completed his fellowship in Medical Oncology at Mass General and Dana-Farber in 2005. Dr. Choy is an Associate Professor at Harvard Medical School and a physician at Mass General Brigham Cancer Institute. His research focuses on developing better treatments for various sarcoma types and he has contributed to numerous clinical trials and publications in the field. Dr. Choy has been recognized as a "Top Doctor" for more than 15 consecutive years by Castle Connolly and featured in Boston Magazine since 2017.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2003 - 2005
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2000 - 2003
New York University School of MedicineClass of 2000
Yale UniversityBS, Molecular Biophysics and Biochemistry, 1993
Certifications & Licensure
ME State Medical License 2021 - 2028
RI State Medical License 2021 - 2028
MA State Medical License 2002 - 2027
NH State Medical License 2021 - 2027
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctor Castle Connolly, 2012, 2014-2025
- Nominee for the "2013 Brian McGovern Award for Clinical Excellence Massachusetts General Physicians Organization Physician Recognition Dinner, 2013
- Honoree Chawla-Rosenfeld Symposium, 2012
Clinical Trials
Publications & Presentations
PubMed
- RINGSIDE Phase II Study of Varegacestat for Treatment of Desmoid Tumors: A Randomized Dose-Finding Clinical Trial.Rashmi Chugh, Arun Singh, Vladimir Andelkovic, Atrayee Basu Mallick, Bruce Brockstein
Journal of Clinical Oncology. 2026-10-08 - Soft Tissue Reporting and Data System (Soft Tissue-RADS): preliminary validation among fellowship-trained musculoskeletal radiologists.Avneesh Chhabra, Ty Subhawong, Angela He, Flavio Duarte Silva, Gitanjali Bajaj
European Radiology. 2026-10-05 - Circulating Tumor DNA Profiling Defines Risk Classification in Patients With Ewing Sarcoma: A Report From the Children's Oncology Group and the LEOPARD Study.David S Shulman, Kelly Klega, Nan Chen, Allen Buxton, Elliot Gohn
Journal of Clinical Oncology. 2026-09-15
Journal Articles
- CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma CellsEdwin Choy, MD, Cellular physiology and biochemistry
- TP53 Mutations Emerge with HDM2 Inhibitor SAR405838 Treatment in De-Differentiated LiposarcomaMark A Dickson, Edwin Choy, Nature
- Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of BoneWojcik J, Rosenberg AE, Bredella MA, Choy E, Nielsen GP, Deshpande V., Am J Surg Pathol., 1/24/2015
Books/Book Chapters
Abstracts/Posters
- Programmed Cell Death Ligant 1 Expression in ChordomaFeng, Y., Shen, J., Gao, Y., Cote, G., Choy, E., Mankin, H., Hornicek, F., and Duan, Z., ORS (Orthopaedic Research Society) 2015 Annual Meeting, Las Vegas, NV, 1/1/2015
- Expression of PIM1 Kinase in Osteosarcoma and the Clinical SignificanceFeng, Y., Gao, Y., Shen, J., Cote, G., Choy, E., Mankin, H., Hornicek, F., and Duan, Z., ORS (Orthopaedic Research Society) 2015 Annual Meeting, Las Vegas, NV, 1/1/2015
- TP53 Mutations Emerge in Circulating Cell-free DNA Obtained from Patients Undergoing Treatment with the HDM2 Antagonist SAR405838Jung, J., Dickson, M., Schwartz, G., Le Cesne, A., Varga, A., Bahleda, R., Wagner, A., Choy, E., de Jonge, M., Light, M., Lee, JS, Mace, S., and Watters, J, Meeting of the American Society of Clinical Oncology, Chicago, IL, 1/1/2015
Lectures
- Presentation of Research Results SNU Sarcoma SymposiumSeoul National University Hospital (SNUH), Seoul, South Korea - 1/1/2015
- A 28 Year Old Woman with Back Pain and a Lesion in the Lumbar SpineMGH Cancer Center - 1/1/2015
- Case Presentation and Discussion of a Pelvic Mucoepithelial CarcinomaBotswana-Harvard AIDS Institute - 1/11/2014
Other
- Osteogenic Sarcoma Staging. Medscape ReferenceChoy E
http://emedicine.medscape.com/article/2007306-overview
1/21/2013 - Osteogenic Sarcoma Treatment ProtocolsChoy E
http://emedicine.medscape.com/article/2006667-overview
1/21/2013 - Leading the Fight Against Childhood CancerWGBH Interview with Jordan Weinstein of NPR's Morning Edition
http://www.wgbh.org/articles/Leading-theFight-Against-Childhood-Cancer-6147
1/2/2012
Press Mentions
World Class Sarcoma and Connective Tissue Cancer Care: Q&A with Dr. Edwin ChoyJuly 22nd, 2025
Sarcoma Highlights from ESMO 2021September 30th, 2021
“Groundbreaking” Therapy May “Change the Way We Think About Cancer Treatment,” Says ExpertAugust 8th, 2024
Professional Memberships
- Member
External Links
- CVhttps://www.massgeneral.org/assets/mgh/pdf/cancer-center/edwin-choy-cv2022-public.pdf
- MGH Profilehttps://www.massgeneral.org/doctors/17884/edwin-choy
- LinkedInhttps://www.linkedin.com/in/edwin-choy-98a8124/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: